2020-11-11T16:37:50-06:00 2019-12-31 KPMG LLP 191 West Nationwide Blvd Ste 500 Columbus OH 432152568 990 2019-01-01 203238867 Alverno Provena Hospital Laboratories Inc % STEVE WOJNICKI ALVE 2199893857 2434 INTERSTATE PLAZA DRIVE HAMMOND IN 46324 STEVEN WOJNICKI VP of Finance & CFO 2199893857 2020-11-09 MOLLIE P LONGHOUSE P00294881 6142492300 2020-11-11 127.0.0.1 31017320203165000000 2020-11-11 P 3D28BA256C41BFA615F16B45A305BCA0B02836B9 D5BC9850BFCDA30ECB79274DA5B672714D46BCB4 2019 2021-01-29 14:40:06Z SAMUEL C TERESE JR 2434 INTERSTATE PLAZA DRIVE HAMMOND IN 46324 149294086 false X ALVERNOLABS.COM X 2005 IN BRINGING CHRIST'S MINISTRY TO THOSE WE SERVE THROUGH TIMELY HIGH-QUALITY LAB TESTING TO OUR 25 NOT-FOR-PROFIT HOSPITALS AND AFFILIATES LOCATED THROUGHOUT ILLINOIS AND INDIANA. 7 7 0 7 0 0 0 0 134424877 148187106 184946 260984 0 0 134609823 148448090 0 0 0 0 0 0 0 0 0 134620359 148458052 134620359 148458052 -10536 -9962 15073573 16234314 14923573 16084314 150000 150000 X BRINGING CHRIST'S MINISTRY TO THOSE WE SERVE THROUGH TIMELY HIGH-QUALITY LABORATORY TESTING TO OUR 25 NOT-FOR-PROFIT HOSPITALS AND AFFILIATES LOCATED THROUGHOUT ILLINOIS AND INDIANA. false false 138078309 148187106 ALVERNO PROVENA HOSPITAL LABORATORIES, INC.'S (APHL) PRIMARY FUNCTION IS TO PROVIDE LABORATORY TESTING SERVICES TO ITS TWENTY-FIVE (25) AFFLIATED NOT-FOR-PROFIT HOSPITALS AND AFFILIATES LOCATED THROUGHOUT ILLINOIS AND INDIANA. THE ORGANIZATION MAINTAINS A STRATEGIC PLAN THAT IS STRUCTURED ON THE FOLLOWING FIVE AREAS: STEWARDSHIP, PEOPLE, SERVICE, GROWTH, AND QUALITY. (CONTINUED IN SCHEDULE O) 138078309 true false false false false false false false false false true true false true true true true false false false false false false false false false false false false true false false false false false false false false false false false false false true false false false true 70 0 true 0 false false false false false false false false false false X 7 7 false false false false true true true true true false false true true true true true true false false false IL IN X STEVE WOJNICKI 2199893857 2434 INTERSTATE PLAZA DRIVE HAMMOND IN 46324 SAMUEL C TERESE CEO/President 32.0 8.0 X 0 613157 40898 STEVEN G WOJNICKI VP Finance 32.0 8.0 X 0 372801 27991 BERNARD H HENRY VP Human Resources 32.0 8.0 X 0 306305 20455 ALEX WLODZIMIERSKI Lab Director III 40.0 0.0 X 0 142391 25305 SHIRLEY J KOREN LAB DIRECTOR III 40.0 0.0 X 0 135851 29208 DEBBIE A YINEMAN Lab Director III 40.0 0.0 X 0 137729 24543 ROBIN ADES Regional Lab Director 40.0 0.0 X 0 143229 17829 MARTHA A LAMPMAN Regional Lab Director 40.0 0.0 X 0 150981 7466 THOMAS GRYZBEK Chair 1.0 1.0 X X 0 0 0 DANA GILBERT Vice Chair 1.0 1.0 X X 0 0 0 MARK FRITSCH MD Director 1.0 1.0 X 0 0 0 KATHLEEN GUNDERSON Director 1.0 1.0 X 0 0 0 VICKIE REZAI MD Director 1.0 1.0 X 0 0 0 BARBARA ANDERSON Director 1.0 1.0 X 0 0 0 JENNIFER MARION Director 1.0 1.0 X 0 0 0 0 2002444 193695 0 false true false PROFESSIONAL CLINICAL LABORATORIES 113 EAST 4TH STREET MICHIGAN CITY IN 46360 LAB & MANAGEMENT 29507400 ALVERNO CLINICAL LABORATORIES LLC 2434 INTERSTATE PLAZA DRIVE HAMMOND IN 46324 LAB & MANAGEMENT 18725733 ARUP LABORATORIES INC PO BOX 27964 SALT LAKE CITY UT 84127 REFERENCE LAB 4229527 AMERIPATH INDIANAPOLIS PC 13179 COLLECTIN CENTER DRIVE CHICAGO IL 606930131 REFERENCE LAB 825431 MEDSPEED PO BOX 190 LAKE GENEVA WI 53147 COURIER 731170 6 0 LAB SERVICES FOR PATRON HOSPITALS 621500 148187106 148187106 148187106 260984 260984 0 0 0 0 0 0 0 0 0 0 0 0 845996 845996 0 0 0 148448090 148187106 0 260984 0 0 0 0 0 0 0 0 0 0 0 2030 2030 44817 44817 0 0 0 41043662 39287071 1756591 0 651721 651721 116111 116111 0 11 11 121617 121617 0 17472 17472 0 0 0 363554 363554 COMPENSATION PAID BY ACL 64980033 59710262 5269771 0 MEDICAL SUPPLIES 19770750 19770750 REFERENCE LABORATORY 10169205 10169205 EQUIPMENT RENT & MAINTENANCE 1920130 1920130 9256939 5950416 3306523 148458052 138078309 10379743 0 0 0 5000 5000 0 0 7914 14904 0 0 0 0 0 0 370924 429654 382702 131143 5328 5328 0 0 13967254 14017849 0 0 0 0 339779 1635764 15073573 16234314 8882904 10110433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6040669 5973881 14923573 16084314 X 150000 150000 0 0 150000 150000 15073573 16234314 -9962 9962 X false true X true false X 5328 5328 MONEY MARKET FUND 14017849 F 14017849 DUE FROM RELATED PARTIES 1635764 1635764 0 DUE TO RELATED PARTIES 4854339 RETIREMENT BENEFIT LIABILITY 1119542 5973881 X 149304048 9962 845996 855958 148448090 148448090 149304048 845996 845996 148458052 148458052 SUPPLEMENTAL INFORMATION 1 SCHEDULE D, PART X, LINE 2 APHL INC. HAS ESTABLISHED ITS STATUS AS AN ORGANIZATION EXEMPT FROM INCOME TAXES UNDER THE INTERNAL REVENUE CODE ("THE CODE") SECTION 501(E) AND THE LAWS OF THE STATES IN WHICH IT OPERATES. A TAX POSITION IS RECOGNIZED AS A BENEFIT ONLY IF IT IS "MORE LIKELY THAN NOT" THAT THE TAX POSITION WOULD BE SUSTAINED IN A TAX EXAMINATION BEING PRESUMED TO OCCUR. THE AMOUNT IS THE LARGEST AMOUNT OF TAX BENEFIT THAT IS GREATER THAN 50% LIKELY OF BEING REALIZED ON EXAMINATION. FOR TAX POSITIONS NOT MEETING THE "MORE LIKELY THAN NOT" TEST, NO TAX BENEFIT IS RECORDED. THE COMPANY RECOGNIZES INTEREST AND PENALTIES RELATED TO UNRECOGNIZED TAX BENEFITS IN INTEREST AND INCOME TAX EXPENSE, RESPECTIVELY. THE COMPANY HAS NO AMOUNTS ACCRUED FOR INTEREST OR PENALTIES AS OF DECEMBER 31, 2019 AND 2018. DUE TO ITS TAX-EXEMPT STATUS, THE COMPANY IS NOT SUBJECT TO U.S. FEDERAL INCOME TAX OR STATE INCOME TAX. THE COMPANY DOES NOT EXPECT THE TOTAL AMOUNT OF UNRECOGNIZED TAX BENEFITS TO SIGNIFICANTLY CHANGE IN THE NEXT 12 MONTHS. TAX RETURNS FILED BY THE COMPANY ARE SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE (IRS) UP TO THREE YEARS FROM THE EXTENDED DUE DATE OF EACH RETURN. TAX RETURNS FILED BY THE COMPANY ARE NO LONGER SUBJECT TO EXAMINATION FOR THE YEARS ENDED DECEMBER 31, 2015 AND PRIOR. SUPPLEMENTAL INFORMATION 2 SCHEDULE D, PART XI, LINE 2D COST OF GOODS SOLD $845,996 SUPPLEMENTAL INFORMATION 3 SCHEDULE D, PART XII, LINE 2D COST OF GOODS SOLD $845,996 false false false false false false false SAMUEL C TERESE CEO/President 0 466614 0 140245 0 6298 0 11200 0 29698 0 654055 0 0 STEVEN G WOJNICKI VP Finance 0 303175 0 68635 0 991 0 11200 0 16791 0 400792 0 0 BERNARD H HENRY VP Human Resources 0 245344 0 55630 0 5331 0 9701 0 10754 0 326760 0 0 MARTHA A LAMPMAN Regional Lab Director 0 149470 0 0 0 1511 0 5955 0 1511 0 158447 0 0 ALEX WLODZIMIERSKI Lab Director III 0 140396 0 0 0 1995 0 5778 0 19527 0 167696 0 0 ROBIN ADES Regional Lab Director 0 142469 0 0 0 760 0 5822 0 12007 0 161058 0 SHIRLEY J KOREN LAB DIRECTOR III 0 135426 0 0 0 425 0 5619 0 23589 0 165059 0 0 DEBBIE A YINEMAN Lab Director III 0 113055 0 0 0 24674 0 4667 0 19876 0 162272 0 0 SUPPLEMENTAL INFORMATION 1 SCH J, PART I, LINE 3 ALVERNO CLINICAL LABORATORIES, LLC (ACL), A RELATED ORGANIZATION IS THE PAY AGENT FOR ALVERNO PROVENA HOSPITAL LABORATORIES, INC. (APHL). ACL USED THE FOLLOWING METHODS TO ESTABLISH COMPENSATION FOR APHL'S TOP MANAGEMENT OFFICIALS: -COMPENSATION COMMITTEE -INDEPENDENT COMPENSATION CONSULTANT -COMPENSATION SURVEY OR STUDY -APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE Form 990 Part III Line 4a PROGRAM SERVICE ACCOMPLISHMENTS APHL'S LONG TERM OBJECTIVE IS TO CONTINUE TO GROW SO AS TO PROVIDE QUALITY LABORATORY SERVICES TO OUR PATRON FAITH BASED HOSPITALS. IN SO DOING, APHL'S LONG TERM OBJECTIVE IS TO CONTROL COSTS, AND TO INCREASE THE NUMBER OF TESTS AVAILABLE, WITH A FOCUS ON HIGHLY RELIABLE SCIENTIFIC TEST RESULTS WHILE BUILDING A CULTURE OF SERVICE. APHL SEEKS TO ATTRACT A WORK FORCE DEDICATED TO SERVICE OF ITS PATIENTS. APHL'S SHORT TERM OBJECTIVES INCLUDE THE ENHANCEMENT OF THE COST MODEL TO IMPROVE THE RELATIVE VALUE UNIT THAT CAPTURES THE COMPLEXITY AND QUANTITATES THE PRODUCTION COST SO AS TO PROVIDE THE COOPERATIVE WITH AN INTEGRATED DELIVERY SYSTEM TO PROVIDE FOR PATIENT NEEDS ON THE PRODUCTION SIDE. THE USE OF LEAN CONCEPTS PROMOTES THE ELIMINATION OF WASTE AND THE EFFICIENT FLOW OF PRODUCTION. SCORE CARDS ARE IN PLACE AND MONITORED FOR QUALITY INTERVENTION NEED. APPROXIMATELY 13,758 TESTS A DAY ARE PERFORMED AT THE CENTRAL LABORATORY WHILE MAINTAINING RAPID RESPONSE LABORATORIES AT EACH HOSPITAL SITE. EACH LABORATORY SITE IS INSPECTED BY CAP AND PROVIDED A CERTIFICATION IN ADDITION TO THE INTERNAL APHL QUALITY DEPARTMENT INSPECTIONS AND PROGRAMS PROMOTING EXCELLENCE IN LABORATORY SCIENCE. Form 990 Part VI Line 6 SECTION A, LINE 6 THE ORGANIZATION HAS TWO CLASSES OF MEMBERS, VOTING AND NON-VOTING. THE ORGANIZATION HAS ONE CLASS OF VOTING MEMBERS, REFERRED TO AS PARTICIPANT HOSPITALS. EACH PARTICIPANT HAS THE RIGHT TO APPOINT BOARD MEMBERS WHO HAVE THE RIGHT TO VOTE ON ALL MATTERS PRESENTED TO THE MEMBERS OF THE CORPORATION, INCLUDING THE ELECTION OF DIRECTORS. THE PATRONS DO NOT HAVE VOTING RIGHTS. CURRENTLY, APHL, INC. HAS THREE PARTICIPANTS AND NO PATRONS. Form 990 Part VI Line 7a PARTICIPANT HOSPITAL SYSTEM REPRESENTATIVES ARE APPOINTED BY THE PARTICIPANT HOSPITAL SYSTEM OF APHL'S PARENT ORGANIZATIONS. THE PARTICIPANT HOSPITAL SYSTEM REPRESENTATIVES CAN ACT ON BEHALF OF THE PARTICIPANT HOSPITAL SYSTEM CEO ON ALL MATTERS. Form 990 Part VI Line 7b THE PARTICIPANT HOSPITAL SYSTEMS SHALL HAVE THE EXCLUSIVE POWER TO: A) APPROVE THE ADMISSION OF ADDITIONAL PARTICIPANTS OF THE CORPORATION; B) APPOINT AND REMOVE DIRECTORS AND FILL VACANCIES ON THE BOARD OF DIRECTORS; C) APPOINT AND REMOVE THE PRESIDENT OF THE CORPORATION; D) APPROVE AMENDMENTS AND/OR RESTATEMENTS FROM TIME TO TIME TO THE ARTICLES PROPOSED BY THE BOARD OF DIRECTORS; E) APPROVE AMENDMENT OR REPEAL OF THE BYLAWS AND THE ADOPTION OF NEW BYLAWS; F) APPROVE THE SALE, LEASE, PURCHASE, EXCHANGE, OR DISPOSITION OF ALL OR SUBSTANTIALLY ALL OF THE PROPERTY AND ASSETS OF THE CORPORATION OR THE DISPOSITION OF ASSETS OF THE CORPORATION OTHER THAN IN THE ORDINARY COURSE OF BUSINESS; G) APPROVE THE VOLUNTARY DISSOLUTION OF THE CORPORATION OR THE MERGER OR CONSOLIDATION OF THE CORPORATION WITH ANOTHER CORPORATION; H) APPROVE THE PLAN FOR ALLOCATION AND DISTRIBUTION OF THE CORPORATION'S PROPERTY UPON DISSOLUTION IF NOT OTHERWISE PROVIDED FOR UNDER THE BYLAWS; I) APPROVE PARTICIPANTS' REQUIRED CAPITAL CONTRIBUTIONS TO THE CORPORATION OR DUES PAYABLE TO THE CORPORATION; J) APPROVE THE INCURRENCE OF DEBT BY THE CORPORATION IN EXCESS OF AMOUNTS DETERMINED FROM TIME TO TIME BY THE PARTICIPANTS; K) ADOPT THE ANNUAL CAPITAL AND OPERATING BUDGETS OF THE COMPANY, AND ANY MATERIAL DEVIATIONS THEREFROM, SUCH ANNUAL BUDGETS TO INCLUDE ANY PREVIOUSLY APPROVED CAPITAL CONTRIBUTIONS; L) ADOPT THE STRATEGIC PLANS FOR THE CORPORATION AND APPROVE ANY MATERIAL CHANGES TO THE SERVICES OFFERED BY THE CORPORATION WHICH ARE NOT EXPRESSLY IDENTIFIED IN THE PREVIOUSLY APPROVED STRATEGIC PLANS; M) ORGANIZE OR ACQUIRE, OR AUTHORIZE THE ORGANIZATION OR ACQUISITION OF, ANY SUBSIDIARY OR AFFILIATE OF THE CORPORATION; AND N) APPROVE ANY AMENDMENTS TO THE COOPERATIVE SERVICES AGREEMENT AMONG THE CORPORATION AND THE PARTICIPANTS, EFFECTIVE AS OF JULY 1, 2005 OR SUCH OTHER DATE AGREED UPON BY THE PARTICIPANTS. Form 990 Part VI Line 11b THE FORM 990 IS REVIEWED IN DETAIL BY THE ORGANIZATION'S MANAGEMENT. THEN A FINAL DRAFT OF THE FULL FORM 990, INCLUDING APPLICABLE SCHEDULES, IS MADE AVAILABLE TO THE FINANCE COMMITTEE AT A REGULARLY SCHEDULED MEETING WITH OUR TAX ADVISORS PRESENT. EACH REMAINING MEMBER OF THE BOARD OF GOVERNANCE IS ALSO PROVIDED A FINAL DRAFT OF THE FULL FORM 990 FOR REVIEW. THESE REVIEWS OCCUR PRIOR TO FILING WITH THE IRS. Form 990 Part VI Line 12c COVERED PERSONS: ALL MANAGEMENT PERSONNEL AND MEMBERS OF THE BOARD OF DIRECTORS ARE COVERED UNDER THE ORGANIZATION'S CONFLICT OF INTEREST POLICY. MANAGEMENT PERSONNEL INCLUDE SUPERVISORS THROUGH THE PRESIDENT/CEO OF THE ORGANIZATION. POLICY SUMMARY: THE CONFLICT OF INTEREST POLICY IS SENT OUT TO COVERED PERSONS FOR REVIEW. EACH PERSON IS REQUIRED TO COMPLETE THE CONFLICT OF INTEREST QUESTIONNAIRE AND RETURN IT. IT IS THE RESPONSIBILITY OF HUMAN RESOURCES AND THE EXECUTIVE ASSISTANT TO ENSURE THE QUESTIONNAIRES ARE RETURNED AND COMPLETED. THE COMPLETED QUESTIONNAIRES ARE FORWARDED TO THE VICE PRESIDENT OF HUMAN RESOURCES FOR REVIEW TO DETERMINE IF CONFLICTS EXIST. AN INTERESTED PERSON HAS A CONFLICT OF INTEREST WITH RESPECT TO A CONTRACT, TRANSACTION OR ARRANGEMENT IN WHICH ALVERNO PROVENA HOSPITAL LABORATORIES, INC. (APHL) IS (OR WOULD BE, IF APPROVED) A PARTY IF THE PERSON HAS, DIRECTLY OR INDIRECTLY, THROUGH A BUSINESS, INVESTMENT, FAMILY OR OTHER RELATIONSHIP: A) AN OWNERSHIP OR INVESTMENT INTEREST IN ANY ENTITY INVOLVED IN SUCH CONTRACT, TRANSACTION OR ARRANGEMENT; B) A COMPENSATION ARRANGEMENT WITH AN INDIVIDUAL OR ENTITY INVOLVED IN SUCH CONTRACT, TRANSACTION OR ARRANGEMENT; C) A POTENTIAL OWNERSHIP OR INVESTMENT INTEREST IN, OR COMPENSATION ARRANGEMENT WITH, AN INDIVIDUAL OR ENTITY WITH WHICH APHL IS NEGOTIATING SUCH CONTRACT, TRANSACTION OR ARRANGEMENT; OR D) A FIDUCIARY POSITION (E.G., MEMBER, OFFICER, DIRECTOR, COMMITTEE MEMBER) WITH RESPECT TO AN ENTITY IN SUCH CONTRACT, TRANSACTION OR ARRANGEMENT; OR E) A NON-ECONOMIC AFFILIATION OR RELATIONSHIP, DIRECTLY (OR INDIRECTLY, THROUGH A THIRD PARTY) WITH AN INDIVIDUAL OR ENTITY WITH WHICH APHL IS NEGOTIATING OR MAINTAINS A CONTRACT. TRANSACTION OR ARRANGMENT SUCH THAT THE AFFILIATION OR RELATIONSHIP COULD RENDER THE INTERESTED PERSON INCAPABLE OF MAKING A DECISION WITH ONLY THE BEST INTERESTS OF APHL IN MIND. IN ADDITION, AN INTERESTED PERSON HAS A CONFLICT OF INTEREST IN ANY EXISTING OR POTENTIAL COMPENSATION ARRANGEMENT BETWEEN APHL AND THAT INTERESTED PERSON OR ANY BUSINESS, INVESTMENT OR FAMILY MEMBER RELATED TO THAT PERSON. FOR PURPOSES OF THIS SECTION, COMPENSATION INCLUDES DIRECT AND INDIRECT REMUNERATION, AS WELL AS GIFTS OR FAVORS THAT ARE SUBSTANTIAL IN NATURE. SERVICE OF INDIVIDUALS ON THE BOARD OF DIRECTORS FOR ALVERNO PROVENA HOSPITAL LABORATORIES, INC. (AND COMMITTEES THEREOF), BOARDS OR COMMITTEES OF THE MEMBER ORGANIZATIONS OR EMPLOYMENT BY A MEMBER ORGANIZATION OR ALVERNO CLINICAL LABORATORIES, A RELATED ORGANIZATION, IS NOT CONSIDERED A CONFLICT OF INTEREST, AS DEFINED IN THE POLICY. THE VP OF HUMAN RESOURCES COMPILES THE RESULTS AND FORWARDS THE RESULTS TO THE CEO. THE ASSESSMENTS OF ANY POTENTIAL CONFLICT ARE MADE IN COLLABORATION WITH LEGAL COUNSEL AS APPROPRIATE. THE CEO REVIEWS ANY CONFLICTS WITH THE BOARD DURING A SCHEDULED BOARD MEETING. POLICY VIOLATIONS: IF THE BOARD OR MANAGERS HAS REASON TO BELIEVE THAT AN INTERESTED PERSON HAS FAILED TO COMPLY WITH THE DISCLOSURE OBLIGATIONS OF THIS POLICY, THE BOARD OF MANAGERS SHALL INFORM THAT PERSON OF THE BASIS FOR ITS BELIEF AND PROVIDE THAT PERSON AN OPPORTUNITY TO ADDRESS THE ALLEGED FAILURE TO DISCLOSE. AFTER HEARING THE RESPONSE OF SUCH A PERSON AND CONDUCTING FURTHER INVESTIGATION AS MAY BE WARRANTED UNDER THE CIRCUMSTANCES, THE BOARD OF MANAGERS SHALL DETERMINE WHETHER SUCH PERSON HAS IN FACT, VIOLATED THE DISCLOSURE REQUIREMENTS OF THE CONFLICT OF INTEREST POLICY. IF THE BOARD DETERMINES THAT THERE HAS BEEN A VIOLATION, THE BOARD SHALL TAKE APPROPRIATE DISCIPLINARY AND CORRECTIVE ACTION, WHICH MAY INCLUDE REMOVAL (IF THE INTERESTED PERSON IS A BOARD OR COMMITTEE MEMBER, DIRECTOR OR MANAGEMENT EMPLOYEE) OR TERMINATION (IF THE INTERESTED PERSON IS AN EMPLOYEE OF ALVERNO PROVENA HOSPITAL LABORATORIES, INC., ALVERNO CLINICAL LABORATORES, LLC OR A MEMBER ORGANIZATION). RESTRICTIONS IMPOSED ON PERSONS WITH A CONFLICT ARE DETERMINED ON A CASE BY CASE BASIS BY THE CEO IN COLLABORATION WITH LEGAL COUNSEL. AS OF THIS DATE, NO MATERIAL CONFLICTS OF INTEREST HAVE BEEN IDENTIFIED. IF A MATERIAL CONFLICT IS IDENTIFIED IN THE FUTURE, THAT PERSON WOULD BE REQUIRED TO RECLUSE THEMSELVES FROM PARTICIPATING IN DECISIONS AND/OR VOTING PRIVILEGES DIRECTLY RELATED TO THE CONFLICT. Form 990 Part VI Line 15a The organization's top management official is paid by Alverno Clinical Laboratories, LLC, a related organization; therefore, this question has been answered no in accordance with the Form 990 instructions. The board of directors appointed a compensation committee, which is a sub-committee of the board. The compensation for the President/CEO is reviewed by system representatives appointed to the Board. Salary increases are approved annually. The budget is recommended for approval or approved annually by the finance committee, board members from each participating system and system representatives appointed to the board by the system CEO's. Form 990 Part VI Line 15b THE ORGANIZATION'S OTHER OFFICERS AND KEY EMPLOYEES ARE PAID BY ALVERNO CLINICAL LABORATORIES, LLC, A RELATED ORGANIZATION; THEREFORE, THIS QUESTION HAS BEEN ANSWERED NO IN ACCORDANCE WITH THE FORM 990 INSTRUCTIONS. SEE NARRATIVE FOR FORM 990, PART VI, SECTION B, LINE 15A. Form 990 Part VI Line 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990 PART IX LINE 11G DESCRIPTION:PURCHASED SVC-OTHER TOTAL FEES:1386823 FORM 990 PART IX LINE 11G DESCRIPTION:PCL Lab Services TOTAL FEES:31866570 FORM 990 PART IX LINE 11G DESCRIPTION:ACL Management Services TOTAL FEES:7790269 ALVERNO LAB LLC HAMMOND IN 46324 HAMMOND IN 46324 203240648 MANAGEMENT SVCS IN NA PROF LIAB LLC MICHIGAN CITY IN 46360 HAMMOND IN 46324 300711211 MEDICAL SERVICES IN NA false false false true true false false false false false false true true false true false false false false SCHEDULE R, PART III LISTED BELOW ARE THE COMPLETE NAMES AND STREET ADDRESSES FOR PART III: 1) ALVERNO CLINICAL LABS, LLC; 2434 INTERSTATE PLAZA DRIVE; HAMMOND, IN 46324 2) PROFESSIONAL CLINIC LABORATORIES, LLC; 2434 INTERSTATE PLAZA DRIVE; HAMMOND, IN 46324